検索結果 - Katia J. Bruxvoort

Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study 著者: Stanley Xu, Vennis Hong, Lina S Sy, Katia J Bruxvoort, Bruno Lewin, Bing Han, Kimberly J Holmquist, Lei Qian

Connect to this object online.

Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines 著者: Katia J Bruxvoort, Lina S Sy, Jeff Slezak, Bradley K Ackerson, Lei Qian, Sijia Qiu, Zendi Solano, Kristi Reynolds

Connect to this object online.

Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study 著者: Stanley Xu, Lina S Sy, Vennis Hong, Kimberly J Holmquist, Lei Qian, Paddy Farrington, Katia J Bruxvoort, Nicola P Klein, Bruce Fireman, Bing Han, Bruno J Lewin

Connect to this object online.

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study 著者: Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng

Connect to this object online.

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages 著者: Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng

Connect to this object online.